U.S. markets open in 8 hours 19 minutes
  • S&P Futures

    3,594.75
    -6.75 (-0.19%)
     
  • Dow Futures

    28,816.00
    +15.00 (+0.05%)
     
  • Nasdaq Futures

    10,974.00
    -61.50 (-0.56%)
     
  • Russell 2000 Futures

    1,670.60
    +0.80 (+0.05%)
     
  • Crude Oil

    81.61
    +2.12 (+2.67%)
     
  • Gold

    1,670.50
    -1.50 (-0.09%)
     
  • Silver

    19.20
    +0.17 (+0.87%)
     
  • EUR/USD

    0.9792
    -0.0009 (-0.09%)
     
  • 10-Yr Bond

    3.8040
    0.0000 (0.00%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1099
    -0.0067 (-0.60%)
     
  • USD/JPY

    144.9170
    +0.1880 (+0.13%)
     
  • BTC-USD

    19,100.77
    -224.82 (-1.16%)
     
  • CMC Crypto 200

    434.14
    -9.29 (-2.09%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    26,091.62
    +154.41 (+0.60%)
     

Teladoc may have to choose between 'the lesser of two evils,' analyst says in downgrade

·1 min read
Teladoc may have to choose between 'the lesser of two evils,' analyst says in downgrade

Shares of Teladoc Health Inc. were dropping more than 6% in Wednesday morning trading after Guggenheim analyst Sandy Draper downgraded the stock to sell from neutral. He wrote that Teladoc's revenue and earnings before interest, depreciation, and amortization (Ebitda) could face further pressure from various macroeconomic factors, including uncertainty that is pushing out sales cycles for Teladoc as well as inflationary constraints on consumers. Draper sees "limited growth" potential in the near